Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Not Confirmed
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Industry Trade Show
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
27 Sep 2024
// CNBCTV
https://www.cnbctv18.com/market/ubs-advises-selling-a-bunch-of-pharma-stocks-zydus-life-aurobindo-pharma-lupin-cipla-sun-pharma-shares-19483349.htm
27 Sep 2024
// INDPHARMAPOST
https://www.indianpharmapost.com/news/zydus-and-csir-cdri-lucknow-to-develop-drug-for-ckd-induced-osteoporosis-16241
17 Sep 2024
// MONEYCONTROL
https://www.moneycontrol.com/news/business/markets/zydus-lifesciences-board-approves-acquisition-of-api-business-of-sterling-biotech-for-rs-84-crore-12823532.html
12 Sep 2024
// ENDPTS
https://endpts.com/fda-sends-warning-letter-to-indian-drugmaker-after-finding-glass-in-injections/
10 Sep 2024
// FDA
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/zydus-lifesciences-limited-685224-08292024
03 Sep 2024
// EXPRESSPHARMA
https://www.expresspharma.in/zydus-gains-final-usfda-approval-for-amantadine-extended-release-capsules-68-5-mg-and-tentative-approval-for-137-mg/
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-08-08
Pay. Date : 2012-12-18
DMF Number : 22999
Submission : 2009-07-31
Status : Active
Type : II
Certificate Number : CEP 2019-009 - Rev 02
Issue Date : 2024-07-05
Type : Chemical
Substance Number : 1699
Status : Valid
Registration Number : 303MF10044
Registrant's Address : Zydus Corporate Park, 3rd Floor, B Wing, Scheme No. 63, Survey No. 536, Plot No. 103, Nr. Nirma University, Nr. Vaishnod
Initial Date of Registration : 2021-03-15
Latest Date of Registration :
Date of Issue : 2019-07-08
Valid Till : 2022-07-07
Written Confirmation Number : WC-0095
Address of the Firm :
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others